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Abstract 
 
Hyperlipidemia is defined as the presence of either hypertriglyceridemia or hypercholesterolemia, which 
could cause atherosclerosis, cardiovascular diseases and certain cancers. Although hyperlipidemia can 
be treated by hypolipidemic drugs, they are limited due to lack of effectiveness and safety. Since 
flavonoids and tannins have been reported to possess antihyperlipidemic activity, it is believed that 
phytochemicals isolated from plants may decrease the lipid levels with lower side effects. Previous 
studies demonstrated that xanthorrhizol (XNT) isolated from Curcuma xanthorrhizza reduced the levels 
of free fatty acid and triglyceride in vivo. However, antiproliferative activity of XNT and its ability to 
inhibit cholesterol uptake and adipogenesis are yet to be reported. In this study, the IC50 values of XNT 
were 15.12 ± 0.68 μg/mL in HT29 cells and 35.07 ± 0.24 μg/mL in 3T3-L1 adipocytes, respectively. 
Cholesterol uptake inhibition study was conducted in HT29 colon cells using fluorescent cholesterol 
analogue NBD. The result showed that XNT (15 μg/mL) siginificantly inhibited the cholesterol uptake by 
up to 37.6 ± 1.53 % relative to control. On the other hand, higher concentration of XNT (50 μg/mL) 
significantly suppressed the growth of 3T3-L1 adipocytes (5.9 ± 0.58 %) compared to 3T3-L1 
preadipocytes (80.42 ± 8.29 %). It was found that XNT (3.125 μg/mL) impeded adipogenesis by 
reducing lipid content of 3T3-L1 adipocytes for 25.37 ± 3.24 % comparable to positive control 
(quercetin), 20.07 ± 8.78%. We postulate that inhibition of cholesterol uptake, adipocyte number and 
adipogenesis may be utilized as treatment modalities to reduce the prevalence of lipidemia. To 
conclude, XNT could be a potential hypolipidemic agent and further studies could be done on its 
mechanism of action. 
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